Related Experiment Video
Updated: May 6, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo
Bruce L Geller1, Kimberly Marshall-Batty, Frederick J Schnell
1Department of Microbiology, Oregon State University.
Background:
Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) are synthetic DNA/RNA analogues that silence expression of specific genes. We studied whether PPMOs targeted to essential genes in Acinetobacter lwoffii and Acinetobacter baumannii are active in vitro and in vivo.
Methods:
PPMOs were evaluated in vitro using minimum inhibitory concentration (MIC) and viability assays, and in vivo using murine pulmonary infection models with intranasal PPMO treatment.
Results:
MICs of PPMOs ranged from 0.1 to 64 µM (approximately 0.6-38 µg/mL). The most effective PPMO tested was (RXR)4-AcpP, which is targeted to acpP. (RXR)4-AcpP reduced viability of A. lwoffii and A. baumannii by >10(3) colony-forming units/mL at 5-8 times MIC. Mice treated with ≥0.25 mg/kg of (RXR)4-AcpP survived longer and had less inflammation and bacterial lung burden than mice treated with a scrambled-sequence PPMO or phosphate-buffered saline. Treatment could be delayed after infection and still increase survival.
Conclusions:
PPMOs targeted to essential genes of A. lwoffii and A. baumannii were bactericidal and had MICs in a clinically relevant range. (RXR)4-AcpP increased survival of mice infected with A. lwoffii or A. baumannii, even when initial treatment was delayed after infection. PPMOs could be a viable therapeutic approach in dealing with multidrug-resistant Acinetobacter species.
Insights
Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) targeting essential genes in Acinetobacter species show promise as a new antibiotic. These PPMOs were effective in vitro and in vivo, increasing survival in a mouse model of infection.
Area of Science:
- Microbiology
- Antimicrobial Research
- Molecular Biology
Background:
- Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) are synthetic nucleic acid analogs designed to silence specific gene expression.
- Acinetobacter species, including A. lwoffii and A. baumannii, are significant opportunistic pathogens, often exhibiting multidrug resistance.
Purpose of the Study:
- To evaluate the in vitro and in vivo efficacy of PPMOs targeting essential genes in Acinetobacter lwoffii and Acinetobacter baumannii.
- To assess the potential of PPMOs as a therapeutic strategy against multidrug-resistant Acinetobacter infections.
Main Methods:
- In vitro studies involved minimum inhibitory concentration (MIC) and viability assays to determine PPMO effectiveness.
- In vivo efficacy was assessed using murine pulmonary infection models with intranasal PPMO administration.
- Survival rates, inflammation, and bacterial lung burden were measured in treated and control mice.
Main Results:
- PPMOs demonstrated bactericidal activity with MICs in a clinically relevant range (0.1 to 64 µM).
- The PPMO (RXR)4-AcpP, targeting the acpP gene, significantly reduced bacterial viability.
- Mice treated with (RXR)4-AcpP showed increased survival, reduced lung inflammation, and lower bacterial burden, even with delayed treatment.
Conclusions:
- PPMOs targeting essential genes are effective bactericidal agents against Acinetobacter species.
- (RXR)4-AcpP significantly improved survival in a mouse model of Acinetobacter infection.
- PPMOs represent a promising therapeutic approach for combating multidrug-resistant Acinetobacter infections.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Inhibitors of Bacterial Protein Synthesis
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis

